merck & co. inc. (MRK:New York)
Transactions by MERCK & CO. INC. (MRK) in the last 6 months
Merck & Co. Inc. (NYSE:MRK) signed a definitive agreement to acquire cCAM Biotherapeutics Ltd. from Arkin Holdings, OrbiMed Israel Partners, a fund managed by OrbiMed Advisors, L.L.C., Pontifax and others shareholders for approximately $610 million in cash on July 28, 2015. An upfront payment of $95 million will be done. As part of consideration, cCAM shareholders are eligible to receive up to $510 million associated with the attainment of certain clinical development, ...
Meytav Technological Incubator
OrbiMed Advisors, L.L.C.
OrbiMed Israel Partners
Roche Holding AG
American Industrial Acquisition Corporation signed an agreement to acquire the manufacturing facility in Arecibo from Merck & Co. Inc. (NYSE:MRK) on April 9, 2015. American Industrial Acquisition Corporation will retain the approximately 200 Merck employees at the Arecibo manufacturing facility.
Arvinas, Inc. announced that it will receive funding from new investor Merck & Co., Inc. on April 7, 2015. The terms of the transaction were not disclosed.
Merck & Co. Inc. (NYSE:MRK) announces a share repurchase program. Under the program, the company will repurchase up to $10,000 million worth of common stock. The repurchases will be made over time in open-market transactions, block transactions on or off an exchange, or in privately negotiated transactions. The shares will be repurchased for its treasury. The program reinforces company's commitment to deliver increased value to the shareholders and the Board's confidence ...
|3M Co||$143.90 USD||+1.18|
|Allergan plc||$312.00 USD||+6.02|
|Amgen Inc||$155.72 USD||+1.74|
|Bayer AG||€120.38 EUR||-0.83|
|Gilead Sciences Inc||$107.99 USD||+1.03|
|View Industry Companies|